General Inquiry is the latest dashboard expanding the capabilities of VisionaryRX by providing deeper insight into drug molecules, forms, strengths, manufacturers, drug master filings, clinical trials, application holders, Medicaid and those multiple relationships.
The latest dashboard enhances VisionaryRX with over 40 million (previously 30) rows of data from 9 (previously 6) different major sources and open architecture for expansion. Data is cleansed, consolidated and presented in related dashboards for research. The typical manual and error prone process of gathering information for drug molecules is removed. What can be done in seconds in VisionaryRX would take days or weeks if done manually. The video below is a quick walkthrough on how you can use it.
Product and business development teams use numerous data sources to get information about drugs in the market. Orange Book from the FDA provides information about application holders, patents and exclusivity. Amongst others, the FDA also provides information about drug master filings and orphaned drugs. The Center for Medicaire and Medicaid services provides information on reimbursements and prescriptions going back many years. The problem with all this data is that it is not always clean or relatable. VisionaryRX is comprised of over 30 million rows of data from 6 different major sources. This data is then cleansed, consolidated and presented in related dashboards for research. The manual and error prone process of gathering information about a drug molecule is removed. What can be done in seconds in VisionaryRX would take days if done manually...and you'd still not get such a comprehensive view.
October 30, 2017
Industry Overview Dashboard designed to provide a high-level view into the U.S. pharmaceutical industry. Try it for free (desktop or tablet recommended)
November 6, 2017
Deeper insight into drug molecules, forms, strengths, manufacturers, drug master filings, clinical trials, application holders, Medicaid and their multiple relationships.
November 14, 2017
Dashboard analysis of U.S. pharmaceutical markets, dosage forms, strengths, pharmacological classes, trends and those relationships.
November 16, 2017
Analytical portals designed for private and purchased sales data providing organizational insight to other dashboards.
November 21, 2017
Comprehensive views of patent information, expiration, floating applications, exclusivity and related drug company profiles.
November 28, 2017
The Orphan Drug dashboard identifies drugs and associated firms in the market that treat rare conditions.